How do people with chronic kidney disease value cancer-related quality of life? (pages 32–41)
GERMAINE WONG, KIRSTEN HOWARD, JEREMY CHAPMAN, CAROL POLLOCK, STEVEN CHADBAN, GLENN SALKELD, ALLISON TONG, NARELLE WILLIAMS, ANGELA WEBSTER and JONATHAN C CRAIG
Article first published online: 28 DEC 2011 | DOI: 10.1111/j.1440-1797.2011.01531.x
This innovative study examines quality of life (QOL) in different stages of CKD including the coexistent hypothetical scenarios of early and advanced stage colorectal cancer. QOL is significantly reduced in CKD and this study shows that coexistent illnesses have the capacity to significantly reduce QOL particularly in late stage disease. The study also demonstrates tools to enable decision cost–utility analyses.